Overview
- 9 inspections across 8 sites are on record.
- 2 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-11-18.
At a glance
Inspections
9
Sites
8
Observations
2
Career since
Mar 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Amy Harper, M.D. | 18 Nov 2022 | Human Drugs | |
| Angela Khaitova, Pharm D | 17 Nov 2022 | Medical Devices & Rad Health | |
| Javairiah Fatima, M.D. | 23 Sep 2022 | Medical Devices & Rad Health | |
| EMERGENT BIOSOLUTIONS, INC. | 2 Sep 2022 | Human Drugs | |
| Novavax, Inc. | 8 Jul 2022 | Biologics |
Sites inspected
Amy Harper, M.D.Richmond, United States1 insp.
Angela Khaitova, Pharm DFlushing, United States1 insp.
Javairiah Fatima, M.D.Washington, United States1 insp.
EMERGENT BIOSOLUTIONS, INC.Gaithersburg, United States1 insp.
Novavax, Inc.Gaithersburg, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Full investigator report
Get the verbatim findings behind Ellen A Humphrey's 2 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site